CN101269160B - 一种治疗三叉神经痛的中药组合物 - Google Patents
一种治疗三叉神经痛的中药组合物 Download PDFInfo
- Publication number
- CN101269160B CN101269160B CN2008100149400A CN200810014940A CN101269160B CN 101269160 B CN101269160 B CN 101269160B CN 2008100149400 A CN2008100149400 A CN 2008100149400A CN 200810014940 A CN200810014940 A CN 200810014940A CN 101269160 B CN101269160 B CN 101269160B
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- radix
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 206010044652 trigeminal neuralgia Diseases 0.000 title abstract description 10
- 239000003814 drug Substances 0.000 claims abstract description 56
- 229940079593 drug Drugs 0.000 claims abstract description 24
- 239000004615 ingredient Substances 0.000 claims abstract description 14
- 238000011282 treatment Methods 0.000 claims description 37
- 241000255791 Bombyx Species 0.000 claims description 14
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 14
- 241000522620 Scorpio Species 0.000 claims description 14
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 14
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 14
- 239000009490 scorpio Substances 0.000 claims description 14
- 208000002193 Pain Diseases 0.000 abstract description 30
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 208000005392 Spasm Diseases 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 2
- 230000035790 physiological processes and functions Effects 0.000 abstract description 2
- 210000001835 viscera Anatomy 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 241000555682 Forsythia x intermedia Species 0.000 abstract 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 abstract 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 abstract 1
- 241000229182 Ledebouriella seseloides Species 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 210000000256 facial nerve Anatomy 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 8
- 206010019233 Headaches Diseases 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 231100000869 headache Toxicity 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- ZESRJSPZRDMNHY-YFWFAHHUSA-N 11-deoxycorticosterone Chemical class O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 ZESRJSPZRDMNHY-YFWFAHHUSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000004404 Intractable Pain Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 208000017515 adrenocortical insufficiency Diseases 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
- 229960000623 carbamazepine Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960002790 phenytoin sodium Drugs 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- FJPYVLNWWICYDW-UHFFFAOYSA-M sodium;5,5-diphenylimidazolidin-1-ide-2,4-dione Chemical compound [Na+].O=C1[N-]C(=O)NC1(C=1C=CC=CC=1)C1=CC=CC=C1 FJPYVLNWWICYDW-UHFFFAOYSA-M 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗三叉神经痛的中药组合物，属中药领域。该种治疗三叉神经痛的中药组合物，由川芎15-25克，忍冬藤15-25克，连翘10-20克，茯苓10-20克，白芍10-20克，半夏10-15克，荆芥10-15克，防风10-15克，枳实10-15克，白芷10-15克，僵蚕10-15克，厚朴10-15克，生地10-15克，全蝎3-6克、细辛3-5克，生甘草3-6克配制而成。先将各原料药的杂质去除，纳诸药于砂锅中加水500毫升，煎煮半小时，一日一剂，分两次服用。本发明能够迅速起到解痉止痛的作用，全面调理脏腑、经络、使三叉神经、面神经恢复正常的生理功能，从而达到长期止痛，彻底治愈。
Description
技术领域
本发明涉及一种治疗三叉神经痛的中药组合物，属中药领域。
背景技术
三叉神经痛是一种发生于三叉神经分布区域内的短暂的、反复发作的剧烈疼痛。分为原发性和继发性两类。前者病因不明；后者由炎症、外伤、肿瘤、血管病等引起。三叉神经痛患者主要发生于中老年人。女性多于男性。疼痛大多为单侧，以面部三叉神经一支或几支分布区内，面颊、上颌、下颌或舌部最为明显，骤然发生的闪电式剧烈面部疼痛为特征，突发突止，间歇期正常。对于三叉神经痛的治疗，西药的一时止痛止痉效果是常优于中药，但西药只能临时止痛，最好用中药治疗。
发明内容
本发明的目的在于克服上述现有技术存在的问题，而提供一种治疗三叉神经痛的中药组合物，它治疗方便安全，有效率高，并且还可以大大减少甚至摆脱对西药副作用较大的药物依赖性。
本发明解决技术问题所采取的技术方案是：
该种治疗三叉神经痛的中药组合物，其特征在于，制成药物有效成分的原料药按下述重量为：川芎15-25克，忍冬藤15-25克，连翘10-20克，茯苓10-20克，白芍10-20克，半夏10-15克，荆芥10-15克，防风10-15克，枳实10-15克，白芷10-15克，僵蚕10-15克，厚朴10-15克，生地10-15克，全蝎3-6克、细辛3-5克，生甘草3-6克。
本发明进一步的技术方案是：该种治疗三叉神经痛的中药组合物，制成药物有效成分的原料药按下述重量为：川芎20克，忍冬藤20克，连翘15克，茯苓15克，白芍15克，半夏12克，荆芥12克，防风12克，枳实12克，白芷10克，僵蚕10克，厚朴10克，生地10克，全蝎5克，细辛3克，生甘草6克。
配制及服用方法：
先将各原料药的杂质去除，纳诸药于砂锅中加水500毫升，煎煮半小时，一日一剂，分两次服用。
药理作用：川芎：味辛，温。入肝、胆经。行气开郁，法风燥湿，活血止痛。治风冷头痛旋晕，胁痛腹疼，寒痹筋挛，经闭，难产，产后瘀阻块痛，痈疽疮疡。用于月经不调，经闭痛经，瘕腹痛，胸胁刺痛，跌扑肿痛，头痛，风湿痹痛。忍冬藤：甘、寒；归肺、心、胃经。清热祛风，活血通络。本品擅清络中之热，通络中之滞，常用于热痹及风热痒痛等症。连翘：连翘：清热，解毒，散结，消肿。治温热，丹毒，斑疹，痈疡肿毒，瘰疬，小便淋闭；咽喉肿痛，风疹。茯苓：甘淡，平。入心、脾、肺经。渗湿利水，益脾和胃，宁心安神。治小便不利，水肿胀满，痰饮咳逆，呕哕，泄泻，遗精，淋浊，惊悸，健忘。白芍：苦酸，凉。入肝、脾经。养血柔肝，缓中止痛，敛阴收汗。治胸腹胁肋疼痛，自汗盗汗，阴虚发热。半夏：燥湿经痰，降逆止呕，消痞散结。治湿痰冷饮，呕吐反胃，痰厥头痛，头晕不眠。荆芥：辛，温。入肺、肝经。发表，祛风，理血；炒炭止血。治感冒发热，头痛，咽喉肿痛，中风口噤，吐血，衄血，便血；崩漏，产后血晕；痈肿，疮疥，瘰疬。防风：辛甘，温。入膀胱、肺、脾经。发表祛风，胜湿，止痛。治外感风寒，头痛，目眩，项强，风寒湿痹，骨节酸痛。枳实：苦，寒。入脾、胃经。破气，散痞，泻痰，消积。治胸腹胀满，胸痹，痞痛，痰癖，水肿，食积，便秘，胃下垂，子宫下垂，脱肛。白芷：辛，温。入肺、髀、胃经。祛风，燥湿，消肿，止痛。治头痛，眉棱骨痛，齿痛，鼻渊，寒湿腹痛，肠风痔漏，赤白带下，痈疽疮疡，皮肤燥痒，疥癣。僵蚕：退热，止咳，化痰，镇静镇惊，消肿，以及调节神经，参与脂肪代谢。厚朴：温中，下气，燥湿，消痰。治胸腹痞满胀痛，反胃，呕吐，宿食不消，痰饮喘咳，寒湿泻痢。生地：苦寒清热，甘寒质润养阴，为清凉滋润之品，擅长于滋阴清热凉血。功效清热凉血，养阴生津，润肠。全蝎：咸辛，平，有毒。足厥阴经。具有熄风止痉，解毒散结痛络止痛之功效，能攻毒拔毒，解瘀散滞，开痰散结，破坚消肿。对于顽固性疼痛，具有明显止痛功效。细辛：辛，温。入肺、肾经。具有散寒解表、祛风除湿、活血化瘀、消炎止痛、清热解毒等功效。治风冷头痛，鼻渊，齿冷，风湿痹痛。甘草：甘，平。归心、肺、脾、胃经。补脾益气，滋咳润肺，缓急解毒，调和百药。主治咽喉肿痛，痛疽疮疡，胃肠道溃疡以及解药毒、食物中毒等。甘草剂有抗炎和抗变态反映的功能，因此在西医临床上主要作为缓和剂。缓解咳嗽，祛痰，治疗咽痛喉炎；甘草次酸有去氧皮质酮类作用，对慢性肾上腺皮质功能减退有良好功效。甘草的黄酮具有消炎、解痉和抗酸作用。
临床80例试验表明：本发明将以上药物组合后，药效具有协同作用，迅速起到解痉止痛的作用，全面调理脏腑、经络、使三叉神经、面神经恢复正常的生理功能，从而达到长期止痛，彻底治愈。该种治疗三叉神经痛的中药组合物不仅药源广泛，且治疗方便安全，有效率高。并且还可以大大减少甚至摆脱对西药副作用较大的苯妥英钠、卡马西平等药物的依赖。
典型病例
例一，于某，男，65岁，济宁人。患有三叉神经病痛二十年，曾在多家医院治疗，效果均不理想，患者身体消瘦，精神欠佳，服用该种治疗三叉神经痛的药物两疗程，精神好转，症状基本消失，又经二个疗程巩固治疗，病情稳定，无其他异常表现，回访未见复发。
例二，姜某，女，42岁，青岛人。患有三叉神经痛近十年，近来发作频繁，每日口服卡马西平8片，也经多处治疗，反复发作。后来她听从了中医的建议改用中药治疗，于是在服用本发明药物两个疗程后，病情稳定，西药停用，巩固治疗三个疗程后，回访无复发。
例三，仲某，女，49岁，天津人。患有三叉神经痛五年余，疼痛时如针刺，每次发作约十五分钟，曾在多家大医院治疗，效果不佳，经服用本发明药物治疗一个疗程后，效果不错，症状基本消失。又经过两个疗程的巩固治疗，未再复发。
例四，吴某，男，38岁，河北人。缘于患者十年前患三叉神经痛，经多次多方治疗病情时轻时重，一个月前疼痛发作次数增加，疼痛加重，伴心烦心慌。经服用本发明药物治疗两个疗程后，自述疼痛缓解，三叉神经痛基本控制，发作次数减少，心慌心烦解除，继服一个疗程，疼痛完全解除。
具体实施方式
例一：一种治疗三叉神经痛的中药组合物，制成药物有效成分的原料药按下述重量为：川芎20克，忍冬藤20克，连翘15克，茯苓15克，白芍15克，半夏12克，荆芥12克，防风12克，枳实12克，白芷10克，僵蚕10克，厚朴10克，生地10克，全蝎5克，细辛3克，生甘草6克。
配制及服用方法：先将各原料药的杂质去除，纳诸药于砂锅中加水500毫升，煎煮半小时，一日一剂，分两次服用。
例二：一种治疗三叉神经痛的中药组合物，制成药物有效成分的原料药按下述重量为：川芎25克，忍冬藤25克，连翘15克，茯苓15克，白芍12克，半夏12克，荆芥12克，防风12克，枳实12克，白芷10克，僵蚕10克，厚朴10克，生地10克，全蝎5克，细辛3克，生甘草6克。配制及服用方法：同例一。
例三：一种治疗三叉神经痛的中药组合物，制成药物有效成分的原料药按下述重量为：川芎20克，忍冬藤20克，连翘12克，茯苓12克，白芍12克，半夏12克，荆芥12克，防风12克，枳实12克，白芷12克，僵蚕10克，厚朴10克，生地10克，全蝎5克，细辛3克，生甘草6克。配制及服用方法：同例一。
例四：一种治疗三叉神经痛的中药组合物，制成药物有效成分的原料药按下述重量为：川芎20克，忍冬藤20克，连翘15克，茯苓15克，白芍15克，半夏15克，荆芥15克，防风15克，枳实12克，白芷12克，僵蚕12克，厚朴10克，生地10克，全蝎5克，细辛3克，生甘草6克。配制及服用方法：同例一。
例五：一种治疗三叉神经痛的中药组合物，制成药物有效成分的原料药按下述重量为：川芎20克，忍冬藤20克，连翘15克，茯苓15克，白芍15克，半夏12克，荆芥12克，防风12克，枳实12克，白芷10克，僵蚕10克，厚朴12克，生地12克，全蝎6克，细辛3克，生甘草5克。配制及服用方法：同例一。
例六：一种治疗三叉神经痛的中药组合物，制成药物有效成分的原料药按下述重量为：川芎20克，忍冬藤20克，连翘15克，茯苓15克，白芍15克，半夏12克，荆芥12克，防风12克，枳实12克，白芷10克，僵蚕15克，厚朴15克，生地15克，全蝎5克，细辛3克，生甘草6克。配制及服用方法：同例一。
例七：一种治疗三叉神经痛的中药组合物，制成药物有效成分的原料药按下述重量为：川芎20克，忍冬藤20克，连翘10克，茯苓10克，白芍10克，半夏12克，荆芥12克，防风12克，枳实12克，白芷10克，僵蚕10克，厚朴10克，生地10克，全蝎5克，细辛3克，生甘草3克。配制及服用方法：同例一。
例八：一种治疗三叉神经痛的中药组合物，制成药物有效成分的原料药按下述重量为：川芎20克，忍冬藤20克，连翘15克，茯苓15克，白芍15克，半夏10克，荆芥10克，防风10克，枳实12克，白芷10克，僵蚕10克，厚朴12克，生地12克，全蝎5克，细辛3克，生甘草6克。配制及服用方法：同例一。
例九：一种治疗三叉神经痛的中药组合物，制成药物有效成分的原料药按下述重量为：川芎15克，忍冬藤20克，连翘15克，茯苓15克，白芍15克，半夏15克，荆芥15克，防风12克，枳实12克，白芷12克，僵蚕12克，厚朴10克，生地10克，全蝎5克，细辛3克，生甘草3克。配制及服用方法：同例一。
Claims (2)
1.一种治疗三叉神经痛的中药组合物，其特征在于，按下述重量的原料药制成药物有效成分：川芎15-25克，忍冬藤15-25克，连翘10-20克，茯苓10-20克，白芍10-20克，半夏10-15克，荆芥10-15克，防风10-15克，枳实10-15克，白芷10-15克，僵蚕10-15克，厚朴10-15克，生地10-15克，全蝎3-6克、细辛3-5克，生甘草3-6克。
2.根据权利要求1所述的一种治疗三叉神经痛的中药组合物，其特征在于，按下述重量的原料药制成药物有效成分：川芎20克，忍冬藤20克，连翘15克，茯苓15克，白芍15克，半夏12克，荆芥12克，防风12克，枳实12克，白芷10克，僵蚕10克，厚朴10克，生地10克，全蝎5克，细辛3克，生甘草6克。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100149400A CN101269160B (zh) | 2008-04-03 | 2008-04-03 | 一种治疗三叉神经痛的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100149400A CN101269160B (zh) | 2008-04-03 | 2008-04-03 | 一种治疗三叉神经痛的中药组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101269160A CN101269160A (zh) | 2008-09-24 |
| CN101269160B true CN101269160B (zh) | 2011-01-05 |
Family
ID=40003551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100149400A Expired - Fee Related CN101269160B (zh) | 2008-04-03 | 2008-04-03 | 一种治疗三叉神经痛的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101269160B (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102846871B (zh) * | 2012-08-31 | 2015-03-18 | 杨高林 | 一种治疗肝火上炎型眶上神经痛的中药制剂及其制备方法 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103301294B (zh) * | 2013-07-05 | 2014-07-16 | 蔡晓青 | 一种治疗原发性三叉神经痛的药物组合物 |
| CN104225105B (zh) * | 2014-09-10 | 2018-06-01 | 杨桂菊 | 用于治疗三叉神经痛的药物制剂 |
| CN104383341A (zh) * | 2014-12-06 | 2015-03-04 | 唐云峰 | 一种用于治疗三叉神经痛的中药组合物 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1356123A (zh) * | 2001-08-16 | 2002-07-03 | 赵西铭 | 一种治疗女性不孕症的药物 |
-
2008
- 2008-04-03 CN CN2008100149400A patent/CN101269160B/zh not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1356123A (zh) * | 2001-08-16 | 2002-07-03 | 赵西铭 | 一种治疗女性不孕症的药物 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102846871B (zh) * | 2012-08-31 | 2015-03-18 | 杨高林 | 一种治疗肝火上炎型眶上神经痛的中药制剂及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101269160A (zh) | 2008-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101926961B (zh) | 一种内服治疗盆腔炎的中药组合物 | |
| CN104547790A (zh) | 一种治疗风湿性关节炎的中药组合物及其制备方法 | |
| CN103550695B (zh) | 一种治疗乳腺癌的药物 | |
| CN105343521A (zh) | 一种治疗颈肩腰背部劳损的中药制剂及制备方法 | |
| CN103316146B (zh) | 一种麻醉用中药制剂 | |
| CN101953926B (zh) | 一种内服治疗痛风的中药组合物 | |
| CN101269160B (zh) | 一种治疗三叉神经痛的中药组合物 | |
| CN104524125A (zh) | 一种治疗湿疹的中药乳膏及其制备方法 | |
| CN103751702B (zh) | 一种治疗乳腺癌的中药 | |
| CN104435326A (zh) | 治疗急性乳腺炎的中药制剂 | |
| CN101164600A (zh) | 一种治疗痤疮、青春痘的药物 | |
| CN103263601A (zh) | 一种加速骨折手术后愈合速度的中药制剂及制备方法 | |
| CN103007093A (zh) | 一种治疗妇科炎症的药物及其制备方法 | |
| CN101569711A (zh) | 一种治疗酒糟鼻的药及其制备方法 | |
| CN105709074A (zh) | 一种治疗风湿性关节炎及骨质增生的药物及制备方法 | |
| CN100490878C (zh) | 治疗牛皮癣的中药 | |
| CN103550383A (zh) | 一种治疗颈椎病的中药组合物 | |
| CN102406879A (zh) | 一种治疗鼻炎的中药组合物 | |
| CN102038889B (zh) | 治疗风湿性心脏病的中药 | |
| CN105663408A (zh) | 一种治疗月经不调及月经量过少的汤剂药物及制备方法 | |
| CN102240384B (zh) | 一种治疗痰瘀互结型癫痫的药物及其制备方法 | |
| CN102284035A (zh) | 一种治疗鼻炎的中药组合物 | |
| CN105902878A (zh) | 一种治疗尿路结石的药物及其制备 | |
| CN106421281A (zh) | 一种治疗急慢性荨麻疹及急性湿疹的中药组合物 | |
| CN105902805A (zh) | 一种产后护理用中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: JIAO XINZHONG Free format text: FORMER OWNER: XU HENGYAN Effective date: 20101026 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Jiao Xinzhong Inventor before: Xu Hengyan |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 265701 THE FIRST ORTHOPEDICS DEPT., LONGKOU PEOPLE S HOSPITAL, NORTH RING ROAD, HUANGCHENG, LONGKOU CITY, SHANDONG PROVINCE TO: 252100 CHIPING COUNTY PEOPLE S HOSPITAL, NO.136, WENHUA ROAD, CHIPING COUNTRY, LIAOCHENG CITY, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: XU HENGYAN TO: JIAO XINZHONG |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20101026 Address after: 252100 Chiping County People's Hospital, 136 Wenhua Road, Chiping, Shandong, Liaocheng Applicant after: Jiao Xinzhong Address before: 265701 Department of Orthopaedics, Longkou City people's Hospital, Huang Bei Cheng Huan Road, Shandong, Longkou City Applicant before: Xu Hengyan |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110105 Termination date: 20110403 |